Effects of morning or bedtime dosing of the valsartan/amlodipine on nocturnal blood pressure and target organ protection in patients with hypertension
Phase of Trial: Phase IV
Latest Information Update: 30 May 2018
Price : $35 *
At a glance
- Drugs Amlodipine/valsartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms CPET
- 30 May 2018 Results of a sub-analysis assessing the association of changes in Brachial/central nocturnal SBP with change in urine albumin-creatinine ratio, published in the American Journal of Hypertension
- 26 Oct 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 29 Sep 2015 Planned End Date changed from 30 Sep 2015 to 14 Aug 2015, as reported by University Hospital Medical Information Network - Japan record.